A phase-II trial of ZIO 101 [darinaparsin] in advanced hepatocellular carcinoma.

Trial Profile

A phase-II trial of ZIO 101 [darinaparsin] in advanced hepatocellular carcinoma.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Nov 2013

At a glance

  • Drugs Darinaparsin (Primary)
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Sponsors ZIOPHARM Oncology
  • Most Recent Events

    • 13 Nov 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 18 Jul 2012 Planned end date changed from 1 Dec 2008 to 1 Jun 2013 as reported by ClinicalTrials.gov.
    • 18 Jul 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top